The beer giant believes its bio-waste products and fermentation knowledge are underutilized resources.
By Mike Pomranz
As the world’s largest brewer, beer will always be Anheuser-Busch InBev’s primary business, but during an investor seminar last week, the Belgium-based behemoth dedicated a surprising amount of time to touting its latest biotech innovations, even suggesting that they could soon see significant revenue-producing alternative protein sources.


Leave a comment